ENDORSE: a prognostic model for endocrine therapy in estrogen‐receptor‐positive breast cancers

Abstract Advanced and metastatic estrogen receptor‐positive (ER+) breast cancers are often endocrine resistant. However, endocrine therapy remains the primary treatment for all advanced ER+ breast cancers. Treatment options that may benefit resistant cancers, such as add‐on drugs that target resista...

Full description

Bibliographic Details
Main Authors: Aritro Nath, Adam L Cohen, Andrea H Bild
Format: Article
Language:English
Published: Springer Nature 2022-06-01
Series:Molecular Systems Biology
Subjects:
Online Access:https://doi.org/10.15252/msb.202110558